Paramyxovirus
Paramyxovirus is a family of viruses, known as Paramyxoviridae, that includes several important human and animal pathogens. These viruses are responsible for a wide range of diseases, including measles, mumps, and respiratory syncytial virus (RSV) infections.
Structure and Classification[edit]
Paramyxoviruses are enveloped, non-segmented, negative-strand RNA viruses. They are classified into two subfamilies: Paramyxovirinae and Pneumovirinae. The Paramyxovirinae subfamily includes the genera Respirovirus, Morbillivirus, Henipavirus, and Rubulavirus, among others. The Pneumovirinae subfamily includes the genera Pneumovirus and Metapneumovirus.
Pathogenesis and Clinical Features[edit]
Paramyxoviruses cause a variety of diseases in humans and animals. For example, the Morbillivirus genus includes the measles virus, which causes measles in humans. The Respirovirus genus includes the human parainfluenza viruses, which cause respiratory illnesses in humans. The Henipavirus genus includes the Nipah virus and Hendra virus, which cause severe disease in humans and animals.
Diagnosis and Treatment[edit]
Diagnosis of paramyxovirus infections is typically based on clinical symptoms and can be confirmed by laboratory testing. Treatment is primarily supportive, as there are currently no antiviral drugs approved for the treatment of paramyxovirus infections. However, vaccines are available for some paramyxoviruses, such as the measles and mumps viruses.
Prevention and Control[edit]
Prevention of paramyxovirus infections is primarily through vaccination. For example, the MMR vaccine provides protection against measles, mumps, and rubella. In addition, good hygiene practices, such as hand washing and avoiding close contact with sick individuals, can help prevent the spread of these viruses.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
